Table 3 The median years to estimated clinical onset (YECO) for each test in MCI and AD patients subdivided according to beta-amyloid abnormality (yes vs no). P-values for two-way (diagnostic group and amyloid abnormality) ANOVAs
Cognitive test, YECO | YECO | p | |||||
|---|---|---|---|---|---|---|---|
MCI | AD | ||||||
PiB + | PiB − | PiB + | PiB − | D | A | DxA | |
Similarities | − 4.1 | − 11.5 | ± 0.0 | − 4.8 | * | ** | ns |
Block Design | − 1.7 | − 3.4 | + 4.9 | + 1.8 | *** | ns | ns |
RAVL learning | − 1.4 | − 6.6 | + 2.7 | + 0.7 | ** | * | ns |
RO retention | − 4.0 | − 8.6 | + 4.1 | − 0.3 | *** | ns | ns |
Digit Symbol | + 1.4 | − 5.1 | + 4.8 | − 1.1 | ns | * | ns |
Mean YECO | − 1.2 | − 5.51 | + 3.8 | + 0.5 | *** | ** | ns |